Bluebook
Diagnostics & Tools March 2021
2021 - March: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- Roche has agreed to acquire GenMark Diagnostics for $1.9bb
- Agilent Technologies has agreed to acquire Resolution Bioscience for approximately $700mm
- Bio-techne has agreed to acquire Asuragen for $320mm